"Both the Entrust delivery system and the EverFlex Stent with the pin-pull delivery system provide enhanced choice and treatment solutions for peripheral arterial disease." Unlike the pull-pin ...

LAS VEGAS--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent at the Vascular ...

The trial demonstrated the proven success of Medtronic’s self-expanding peripheral stent system – EverFlex – in offering sustained patency in the treatment of peripheral artery disease (PAD).

Stent Delivery System Offers Controlled, One-Handed Delivery, Greater Accuracy and Ease of Use DUBLIN, Ireland-- Covidien plc today announced the launch of its EverFlex™ Self-expanding Peripheral ...

The new Entrust delivery system enables physicians to place Medtronic's EverFlex(TM) self-expanding peripheral stent, while maintaining a low profile and providing the ease of a one-handed device.

approval from the U.S. Food and Drug Administration (F.D.A.) to study the use of its Protege EverFlex Self-Expanding Stent System in the treatment of peripheral artery disease (P.A.D.). The trial ...

Some trials focused on use of biliary stents in arteries are under way. For example, the device maker EV3 has trials started in both Europe and the United States for use of its EverFlex biliary ...

Covidien, a leading global provider of healthcare products, today announced CE Mark approval for its EverFlex TM Self-expanding Peripheral Stent with Entrust TM Delivery System. Covidien received ...

Of the 150 patients enrolled in the studies, 75 were treated with the Visi-Pro™ balloon expandable stent system in VISIBILITY Iliac, and 75 were treated with either the EverFlex™ self ...

The new Entrust delivery system enables physicians to place Medtronic`s EverFlex(TM) self-expanding peripheral stent, while maintaining a low profile and providing the ease of a one-handed device.